23392: In silico analyzes of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution February 7, 2024 Article 2 of 21038
23391: Random forest analysis of midbrain hypometabolism using [18F]-FDG PET identifies Parkinson’s disease at the subject-level February 7, 2024 Article 3 of 21038
23390: Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease February 7, 2024 Article 4 of 21038
23389: Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort February 7, 2024 Article 5 of 21038
23388: The presence of anhedonia in individuals with subacute and chronic stroke: an exploratory cohort study February 7, 2024 Article 6 of 21038
23387: Serum proteomic biomarker investigation of vascular depression using data-independent acquisition: a pilot study February 7, 2024 Article 7 of 21038
23386: Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease February 7, 2024 Article 8 of 21038
23379: Are body temperature and depression linked? Science says, yes February 7, 2024 Article 9 of 21038
